Katja Sæterhaug Bye

Katja Sæterhaug Bye has a diverse work experience. Katja Sæterhaug started their career as a Medical Secretary at FINNMARKSSYKEHUSET HF in 2019 and 2020. Katja Sæterhaug then joined Abbott Diagnostics Technologies AS as a Scientist from June 2021 to April 2022. Currently, they are associated with Nykode Therapeutics. Katja Sæterhaug started as a Lab Manager in April 2022 and later transitioned to the role of an Analytical Scientist from April 2023.

Katja Sæterhaug Bye pursued their education in a chronological order starting in 2016. Katja Sæterhaug enrolled at the Norwegian University of Science and Technology (NTNU) and completed three years of an integrated master's degree with a specialization in molecular biology. This educational path in biotechnology spanned from 2016 to 2019. In 2019, they also briefly attended UNSW for a master's degree in Molecular Medicine. Later in the same year, Katja Sæterhaug Bye returned to NTNU to complete their master's degree in Molecular Medicine, which they completed in 2021.